Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,174) with videos related to
Page
of 118
Sort By:
The Journal of Urology
|
October 24, 2002
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109
Isaac J Powell, Catherine M Tangen, Gary J Miller, et al.
BJU International
|
December 2, 2011
Testosterone in prostate cancer: the Bethesda consensus
Bob Djavan, James Eastham, Leonard Gomella, et al.
The Canadian Journal of Urology
|
February 18, 2020
Assessment of high-grade prostate cancer risk using prostate cancer biomarkers
Whitney N Stanton, E David Crawford, Paul B Arangua, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 3, 2012
Malakoplakia after renal transplantation in the current era of immunosuppressive therapy: case report and literature review
C A Leão, M I S Duarte, C Gamba, et al.
Urology
|
July 17, 2012
Role of testosterone in managing advanced prostate cancer
Kyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group
Christopher W Ryan, Bryan H Goldman, Primo N Lara, et al.
JAMA
|
November 16, 2006
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial
Ian M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 19, 2013
Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors
L S Azevedo, J Gerhard, J L Miraglia, et al.
Urology
|
March 26, 2014
Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix
E David Crawford, Neal D Shore, Judd W Moul, et al.
Cancer
|
April 3, 2008
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426)
A Oliver Sartor, Catherine M Tangen, Maha H A Hussain, et al.
Page
of 118
Search research articles
Search
Showing results (991-1000 of 1,174) with videos related to
Sort By:
Page
of 118
The Journal of Urology
|
October 24, 2002
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109
Isaac J Powell, Catherine M Tangen, Gary J Miller, et al.
BJU International
|
December 2, 2011
Testosterone in prostate cancer: the Bethesda consensus
Bob Djavan, James Eastham, Leonard Gomella, et al.
The Canadian Journal of Urology
|
February 18, 2020
Assessment of high-grade prostate cancer risk using prostate cancer biomarkers
Whitney N Stanton, E David Crawford, Paul B Arangua, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 3, 2012
Malakoplakia after renal transplantation in the current era of immunosuppressive therapy: case report and literature review
C A Leão, M I S Duarte, C Gamba, et al.
Urology
|
July 17, 2012
Role of testosterone in managing advanced prostate cancer
Kyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group
Christopher W Ryan, Bryan H Goldman, Primo N Lara, et al.
JAMA
|
November 16, 2006
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial
Ian M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 19, 2013
Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors
L S Azevedo, J Gerhard, J L Miraglia, et al.
Urology
|
March 26, 2014
Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix
E David Crawford, Neal D Shore, Judd W Moul, et al.
Cancer
|
April 3, 2008
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426)
A Oliver Sartor, Catherine M Tangen, Maha H A Hussain, et al.
Page
of 118